By binding to IL6ST mRNA, miR‐224‐5p reduces IL6ST expression, suppresses the activation of the JAK2/STAT3 signaling pathway, and ultimately inhibits NSCLC cell proliferation and tumor growth. The gene discussed is STAT3; the disease is neoplasm.